Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
01/2002
01/17/2002WO2002004681A2 Method of detection by enhancement of silver staining
01/17/2002WO2002004680A2 Real-time sequence determination
01/17/2002WO2002004679A1 A process for detecting a nucleic acid target
01/17/2002WO2002004678A2 Methods and compositions for diagnosing and treating preeclampsia and gestational trophoblast disorders
01/17/2002WO2002004677A2 Methods for diagnosis and treatment of psychiatric disorders
01/17/2002WO2002004676A2 Composite and averaged hybridizations
01/17/2002WO2002004675A1 Haplotypes of the kcnb1 gene
01/17/2002WO2002004674A2 Transposon mediated multiplex sequencing
01/17/2002WO2002004673A1 Method for detecting sequence variation of nucleic acid
01/17/2002WO2002004672A2 Diagnostic method for the identification of foetal dna in a maternal sample
01/17/2002WO2002004671A2 Improved binding interactions in dipstick assays
01/17/2002WO2002004670A2 Improved capture and detection of target nucleic acid in dipstick assays
01/17/2002WO2002004669A2 Improved capture and detection format versatility for dipstick assays
01/17/2002WO2002004668A2 Improved capture and detection of target nucleic acid in dipstick assays
01/17/2002WO2002004667A2 Improved detection signal and capture in dipstick assays
01/17/2002WO2002004666A2 Decondensation of dna
01/17/2002WO2002004665A2 Method with a wide range of applications, for identifying modulators of g-protein-coupled receptors
01/17/2002WO2002004663A2 A nucleic acid-based method for tree phenotype prediction
01/17/2002WO2002004662A1 Proteins associated with aging
01/17/2002WO2002004661A2 Methods for classifying nucleic acids and polypeptides
01/17/2002WO2002004660A2 Method for testing for inhibition of drug-metabolizing cytochrome p450 isozymes
01/17/2002WO2002004659A2 Relative rates of cytochrome p450 metabolism
01/17/2002WO2002004656A2 Bio-probes and use thereof
01/17/2002WO2002004655A2 Cation mediated triplex hybridization assay
01/17/2002WO2002004654A2 Method for determining an<i> in vitro</i> cell model imitating the expression profile of a gene of interest in an <i>in vivo</i> cell
01/17/2002WO2002004647A1 Dna sequences coding for a polyol carrier and use thereof, in particular for preparing transgenic plants
01/17/2002WO2002004641A1 Novel g protein-coupled receptor protein and dna thereof
01/17/2002WO2002004636A1 NOVEL α-CATENIN EXPRESSED IN HEART AND TESTIS
01/17/2002WO2002004628A2 Method of identifying a binding partner of a gene product
01/17/2002WO2002004621A2 Methods of creating constructs useful for introducing sequences into embryonic stem cells
01/17/2002WO2002004619A2 Dehydroquinate dehydrase/shikimate dehydrogenase as a herbicide target
01/17/2002WO2002004612A2 Drug metabolizing enzymes
01/17/2002WO2002004611A2 Aminoacyl trna synthetases
01/17/2002WO2002004602A1 Transformed yeast presenting protein a on the cell surface layer
01/17/2002WO2002004596A2 Diagnosing and treating cancer cells using mutant viruses
01/17/2002WO2002004595A2 Production of chimeric human papillomavirus
01/17/2002WO2002004555A1 Superparamagnetic pearl polymers
01/17/2002WO2002004526A2 Production of a cellulose-like polysaccharide by peudomonas fluorescens
01/17/2002WO2002004523A2 Artificial antibody polypeptides
01/17/2002WO2002004520A2 Transporters and ion channels
01/17/2002WO2002004514A2 Compositions and methods for the therapy and diagnosis of lung cancer
01/17/2002WO2002004513A2 Down syndrome critical region 1-like 1 proteins
01/17/2002WO2002004511A2 CHROMOSOME 3p21.3 GENES ARE TUMOR SUPPRESSORS
01/17/2002WO2002004509A2 Gene expression, genome alteration and reporter expression in myofibroblasts and myofibroblast-like cells
01/17/2002WO2002004491A2 Methods and compositions relating to muscle selective calcineurin interacting protein (mcip)
01/17/2002WO2002004490A2 Lipid metabolism molecules
01/17/2002WO2002004489A2 Polymorphic kinase anchor proteins and nucleic acids encoding the same
01/17/2002WO2002004485A1 Haemagglutinin antigen
01/17/2002WO2002004482A1 Methods for preventing neural tissue damage and for the treatment of alpha-synuclein diseases
01/17/2002WO2002004470A2 Haplotypes of the gcnt1 gene
01/17/2002WO2002004431A1 Silent mark for oil product and detection method thereto
01/17/2002WO2002004122A2 Improved stability of hybridisation interactions in dipstick assays
01/17/2002WO2002004111A2 Polymer chip
01/17/2002WO2002004029A1 Olfactory neuron cultures and method of making and using the same
01/17/2002WO2002004022A1 High fidelity polymerases and uses thereof
01/17/2002WO2002003919A2 Structural targets in hepatitis c virus ires element
01/17/2002WO2002003849A2 Microarray method of genotyping multiple samples at multiple loci
01/17/2002WO2001072962A3 Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
01/17/2002WO2001065994A3 Method of and kit for assessing responsiveness of cancer patients to antifolate chemotherapy
01/17/2002WO2001051922A3 Identification of peripheral benzodiazepine receptor binding agents
01/17/2002WO2001049838A3 Cis-acting regulatory nucleic acid sequences in the parathyroid hormone 3'-untranslated region
01/17/2002WO2001047950A3 Basolateral sorting signal based on scf peptide and inhibitors thereof
01/17/2002WO2001044448A3 Human oxidoreductase proteins
01/17/2002WO2001044291A3 Polynucleotid encoding the rg1 polypeptide
01/17/2002WO2001042502A3 Methods for disease detection
01/17/2002WO2001042299A3 Hepatitis virus sentinel virus i (svi)
01/17/2002WO2001042211A3 Detection of transmembrane potentials by optical methods
01/17/2002WO2001040758A3 A method for high throughput thermodynamic screening of ligands
01/17/2002WO2001040446A3 Pour-on formulations
01/17/2002WO2001038878A3 Pin1 as a marker for abnormal cell growth
01/17/2002WO2001036965A3 Electric substance detectors comprising cellular material
01/17/2002WO2001036682A3 Long oligonucleotide arrays
01/17/2002WO2001036619A3 Cloning and characterization of the cap gene promoter
01/17/2002WO2001036461A3 Compositions and methods for regulating tumor-associated antigen expression
01/17/2002WO2001034846A3 Direct mapping of dna chips to detector arrays
01/17/2002WO2001034833A3 Regulating endogenous inhibitor at atp synthase
01/17/2002WO2001034771A3 METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING CHROMOSOME 18q RELATED DISORDERS
01/17/2002WO2001032876A3 Compositions and methods for determining interactions of mitochondrial components, and for identifying agents that alter such interactions
01/17/2002WO2001032696A3 Traf family proteins
01/17/2002WO2001031344A3 Glycerol as a predictor of glucose tolerance
01/17/2002WO2001031051A3 Antisense modulation of protein kinase c-theta expression
01/17/2002WO2001031011A3 Gene mining system and method
01/17/2002WO2001029260A3 Allele detection using primer extension with sequence-coded identity tags
01/17/2002WO2001029259A3 Identification of alleles
01/17/2002WO2001029072A3 P15paf cell cycle proteins associated with pcna, compositions and methods of use
01/17/2002WO2001027317A3 Method for distinguishing 5-position methylation changes
01/17/2002WO2001027290A3 Aortic carboxypeptidase-like protein and nucleic acids encoding same
01/17/2002WO2001021839A3 Gene expression profiles
01/17/2002WO2001021310A3 Device for rapid dna sample processing with integrated liquid handling, thermocycling, and purification
01/17/2002WO2001020019A3 Implantable glucose sensor
01/17/2002WO2001020010A3 Transcriptionally silenced plant genes
01/17/2002WO2001016377A3 Diagnostics and therapeutics for osteoporosis
01/17/2002WO2001016366A3 Template-dependent nucleic acid polymerization using oligonucleotide triphosphates building blocks
01/17/2002WO2001016293A3 Dna encoding the human serine protease t
01/17/2002WO2001013118A3 Methods and compositions for diagnosis of hepatoma
01/17/2002WO2001013117A3 Proteins, genes and their use for diagnosis and treatment of breast cancer
01/17/2002WO2001012598A3 METHODS OF INHIBITING BINDING OF β-SHEET FIBRIL TO RAGE AND CONSEQUENCES THEREOF
01/17/2002WO2001007471A3 Cell cycle and proliferation proteins
01/17/2002WO2001007087A3 Enzyme catalyzed anti-infective therapeutic agents
01/17/2002WO2001000669A3 A bap28 gene and protein